This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Virtual ClinicalTrials transcend geographic, mobility and economic barriers. Clinicaltrials are medical research projects involving human participants. However, the costs of conducting a full-scale clinicaltrial can be prohibitive, posing barriers to research for cannabis companies.
The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable ClinicalTrials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinicaltrials in the areas of psychedelics and nutraceuticals, among other substances of study.
(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. ClinicalTrial Sample Size.
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinicalresearch is extremely difficult to conduct. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.
Their position as therapeutic practitioners, as well as their work in conducting the kind of clinicaltrials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.
. * The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. More than 80% of survey respondents indicated strong interest in learning more information about a clinicaltrial, and more than half were interested in enrolling in a clinicaltrial.
Both IBD and IBS have a major impact on the quality of life and on the ability to do simple things such as eat, sleep, and work. Individuals suffering from IBS usually only end up at the doctor’s office when there has been significant weight-loss, diarrhea during sleep, rectal bleeding, difficulty swallowing, and persistent pain.
Further research led them to discover that the key to an effective prophylactic is the combination of the two hormones. This was the birth of the world’s first sleeping pill. Leo Sternback, a Polish immigrant living in America, developed Valium from discarded chemical compounds from his experiments to create new dyes.
These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.
But this has failed in the past and could prevent measures from moving forward this time unless new research could be presented to sway the state medical board’s decision. ” One Ohio Physician Embraces Cannabis Research But Denies Effectiveness . Research Shows to be Supportive Despite it All.
Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. Clinical Evidence and Research Findings Research into the efficacy of medical marijuana for MS management has yielded promising results.
Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.
He also made a point of noting that while the cannabis creams and spray he uses have reduced stiffness and pain in his hands, and have helped him sleep – they do not get him high. It’s helped me incredibly, with pain, with sleep, with anxiety. People think I must be getting high all the time. Nothing is further from the truth.”.
The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Research on cannabis and IBS.
In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.
–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS
On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Clinicaltrials show that Epidiolex significantly reduces seizure frequency.
This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research. CBD may also help alleviate anxiety and improve sleep, which can be beneficial for patients with chronic pain. Some patients may also develop a cannabis dependence.
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. Researchers believe cannabis contains over 100 unique chemical compounds! Fortunately in 2014, the Federal Farm Bill re-opened the door for industrial hemp research. What makes CBD special?
DENVER–(BUSINESS WIRE)– Ripple , Colorado’s trusted cannabis edibles brand and pioneer of fast-acting and clinically proven technology, is leading the way in cannabis wellness with new Ripple Sleep QuickDissolves and Ripple Sleep QuickGummies. faster), and Ripple Dissolvables (1.9X
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. Further research is needed to elucidate the clinical role and underlying biological mechanisms of action of cannabidiol-based extract in patients with autism spectrum disorder.”.
The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.
As researchers explore new therapeutic frontiers, recent investigations into cannabinoids have sparked interest in the scientific community and among families seeking hope. While discussing cannabinoid therapy with my patients, I often share that we’re not just treating chorea or sleep disturbances we’re preserving moments.
Automation in agriculture, 3-million-square-feet of cultivable land, research in biosciences, clean renewable energy, high connectivity and the speedy processing of licenses differentiate Denmark from its counterparts in Europe and elsewhere. The roadmap ahead includes clinicaltrials and more research in Denmark.
VA scientists may conduct research on marijuana benefits and risks, and potential for abuse, under regulatory approval. Research suggests that marijuana may work in a number of different ways to decrease PTSD symptoms. VA pharmacies may not fill prescriptions for medical marijuana. You’re Not Alone.
A growing body of research suggests that probiotics can help protect us from illness and disease, improve our mental health, and strengthen our immune system. He adds that research has shown that probiotics can help the immune system produce more antibodies to fight off viruses and bacteria. Introduction.
Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. However, deeper research is needed to better understand its roles. Apart from this, various clinicaltrials are done for multiple conditions. Alcohol use or alcohol withdrawal.
Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC. D8 may well assist with relaxation and sleep.
Research on CBD ( cannabidiol ) shows that it has vast therapeutic properties. The findings were confirmed by similar research conduction in the following year. The findings were confirmed by similar research conduction in the following year. In June of 2019, the FDA in the U.S.
However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.
As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD. Current Cocaine Treatments. CBD & Cocaine: Scientific Review. mice/rats).
This drastically limits the research opportunities and funding available for cannabis studies. Most cannabis research studies and clinicaltrials in recent years required researchers to administer THC doses orally in pill form. In particular, indica strains can help increase appetite and improve sleep quality.
For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content